Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Treatment of Legionnaires’ disease: Macrolides or fluoroquinolones? (CROSBI ID 606500)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Kuzman, Ilija ; Puljiz, Ivan ; Civljak, Rok Treatment of Legionnaires’ disease: Macrolides or fluoroquinolones?. 2012

Podaci o odgovornosti

Kuzman, Ilija ; Puljiz, Ivan ; Civljak, Rok

engleski

Treatment of Legionnaires’ disease: Macrolides or fluoroquinolones?

AQ total of 320 patients with confirmed LD werw hospitalized during the last 12 years. Out of them, 80 were treated with antibiotics before hospitalization. 182 patients were treated in the hospital initially with appropriate antibiotics while 48 patients received inappropriate antibiotics. Azithromycin monotherapy was administered in 43, moxifloxacin in 29 and doxycycline in 14 patients. Time of apirexia was significantly longer in the azithromycin monotherapy group (2.8 days) compared to the moxifloxacin group (2.0 days). The results suggest that moxifloxacin may have a superior clinical response compared to azithromycin with regardes to de fefervescence.

Legionnaires disease; Treatment; Fluoroquinolones; Macrolides

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2012.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

3th Southeast European Conference on Chemotherapy and Infections.

pozvano predavanje

08.11.2012-11.11.2012

Dubrovnik, Hrvatska

Povezanost rada

Kliničke medicinske znanosti